-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Intellipharmaceutics International Inc. quarterly Cost of Revenue history and growth rate from Q3 2022 to Q3 2023.
- Intellipharmaceutics International Inc. Cost of Revenue for the quarter ending August 31, 2023 was $17.4K.